Tumor stiffness measured by 3D magnetic resonance elastography can help predict the aggressiveness of endometrial carcinoma: preliminary findings

Table 2 Categorization of endometrial cancer with corresponding stiffness, tumor size, and ADC values

Category	n	MRE		Tumor size		DWI
Category	n	Stiffness (kPa)	pvalue	Diameter(cm)	pvalue	ADC(×10^− 3mm²/s)	pvalue
Tumor types			0.136		0.973		0.777
Type I	12	2.88 ± 0.85		5.45 ± 3.92		753.15 ± 84.10
Type II	3	3.67 ± 0.58		5.54 ± 2.63		737.66 ± 77.52
Tumor grades			0.028*		0.109		0.726
Well/Moderately differentiated	7	2.55 ± 0.82		3.86 ± 2.07		758.24 ± 72.51
Poorly differentiated	8	3.47 ± 0.64		6.88 ± 4.20		742.88 ± 91.01
FIGO stage			0.030*		0.030*		0.716
I	10	2.72 ± 0.76		4.09 ± 2.53		755.68 ± 85.85
II/III	5	3.69 ± 0.65		8.24 ± 4.12		738.78 ± 76.02
Myometrial invasion			0.009*		0.089		0.979
<50 %	9	2.61 ± 0.72		3.91 ± 1.85		750.51 ± 93.52
≥ 50 %	6	3.68 ± 0.59		7.81 ± 4.50		749.35 ± 63.91

MRE magnetic resonance elastography, DWI diffusion-weighted imaging, ADC Apparent diffusion coefficient, FIGO International Federation of Gynecology and Obstetrics, * p < 0.05

ISSN: 1470-7330